Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Ampio Pharm is a biotechnology business based in the US. Ampio Pharm shares (AMPE) are listed on the NYSE MKT and all prices are listed in US Dollars. Ampio Pharm employs 9 staff and has a market cap (total outstanding shares value) of 0.00.
Finder Award
SoFi Invest
tastyworks
| Latest market close | $0.28 |
|---|---|
| 52-week range | $0.20 - $9.71 |
| 50-day moving average | $0.31 |
| 200-day moving average | $1.75 |
| Wall St. target price | $2.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.12 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.2835 from 2023-01-26
| 1 week (2023-01-20) | 5.00% |
|---|---|
| 1 month (2022-12-27) | 28.45% |
| 3 months (2022-10-27) | 845.00% |
| 6 months (2022-07-27) | 77.19% |
| 1 year (2022-01-24) | -40.94% |
|---|---|
| 2 years (2021-01-27) | -81.94% |
| 3 years (2020-01-27) | 0.692 |
| 5 years (2018-01-26) | 2.72 |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -81.42% |
| Return on equity TTM | -130.71% |
| Profit margin | 0% |
| Book value | $0.92 |
| Market capitalisation | $4.1 million |
TTM: trailing 12 months
We're not expecting Ampio Pharm to pay a dividend over the next 12 months.
Ampio Pharm's shares were split on a 1:15 basis on 9 November 2022. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ampio Pharm shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Ampio Pharm shares which in turn could have impacted Ampio Pharm's share price.
Over the last 12 months, Ampio Pharm's shares have ranged in value from as little as $0.199 up to $9.705. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Ampio Pharm's is 1.685. This would suggest that Ampio Pharm's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Ampio Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado. .
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
